Leigh MacMillan

May 10, 2012

Probing epilepsy’s molecular sparks

Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.

By Leigh MacMillan
April 30, 2012

Better blood pressure-reducing drugs?

A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.

By Leigh MacMillan
April 20, 2012

Neuronal clues to cholesterol-defect disorder

Antioxidants may be a beneficial treatment for an inherited genetic disorder.

By Leigh MacMillan
April 17, 2012

Pathways to delirium in the ICU

Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.

By Leigh MacMillan
lungs
April 13, 2012

Researchers spot Achilles’ heel in respiratory virus

A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults.

By Leigh MacMillan
April 6, 2012

New tool hooks heart failure drugs

A new screening tool – using glowing fish embryos – could identify therapeutics for myocardial hypertrophy and heart failure.

By Leigh MacMillan
April 6, 2012

Plant compound quells inflammation

Berberine, an herbal remedy for diarrhea and intestinal parasites, may be an effective treatment for gastrointestinal inflammatory diseases.
By Leigh MacMillan
March 21, 2012

Obesity turns “good” cholesterol bad

Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol.
By Leigh MacMillan
March 19, 2012

iPOND method goes fishing for proteins

A new tool will allow researchers to identify proteins involved in DNA replication and damage repair, processes that go awry in cancer.
By Leigh MacMillan
March 3, 2012

Reversing lipid woes in cystic fibrosis

Abnormal levels of fatty acids in the blood and tissues of patients with cystic fibrosis may be reversed by supplementation with the fatty acids DHA and EPA.
By Leigh MacMillan
March 2, 2012

‘Detangler’ binds, bends and cuts DNA

New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.
By Leigh MacMillan
February 20, 2012

Stem cells take heart

Signaling pathway discoveries suggest ways to induce stem cells to become cardiac muscle cells, which could be useful for regenerating damaged heart muscle.
By Leigh MacMillan
1 … 70 71 72 73 74 75